Recent studies demonstrated that impaired intracellular calcium balance is implicated in the development of diabetic polyneuropathy [48], while calcimimetic can deter the progression of neuropathy by ameliorating inflammation, apoptosis, and autophagy through increased expression of the calcium-sensing receptors [49]. The gene discussed is CASR; the disease is diabetic polyneuropathy.